US Stock MarketDetailed Quotes

Summit Therapeutics (SMMT)

Watchlist
  • 15.550
  • -0.280-1.77%
Close Oct 22 16:00 ET
  • 15.619
  • +0.069+0.44%
Post 20:02 ET
12.44BMarket CapLossP/E (TTM)

Summit Therapeutics (SMMT) Income Statement

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: USD
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
2022/Q3
2022/Q2
2022/Q1
2021/Q4
2021/Q3
Total Revenue as Reported
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
----
----
-100.00%0.00
-83.19%220.00K
+312.28%235.00K
+30.21%250.00K
+35.68%251.00K
+623.20%1.31M
Total Operating Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-83.19%220.00K
+312.28%235.00K
+30.21%250.00K
+35.68%251.00K
+623.20%1.31M
Operating Expense
-61.21%220.50M
+192.01%195.21M
+242.80%224.88M
+301.20%234.21M
+1174.24%568.44M
+57.71%66.85M
+81.17%65.60M
+184.88%58.38M
+182.45%44.61M
+161.03%42.39M
+206.06%36.21M
+19.42%20.49M
+22.18%15.79M
-27.53%16.24M
-54.99%11.83M
-17.48%17.16M
-45.66%12.93M
+30.93%22.41M
+124.50%26.29M
+27.87%20.80M
Selling and Admin Expenses
-82.59%62.76M
+301.60%62.59M
+445.67%77.58M
+399.25%103.12M
+2509.44%360.42M
+35.34%15.59M
+34.46%14.22M
+280.09%20.65M
+118.68%13.81M
+65.94%11.52M
+39.54%10.57M
-2.49%5.43M
-8.90%6.32M
+4.22%6.94M
-2.46%7.58M
-1.57%5.57M
+15.86%6.93M
+59.12%6.66M
+158.28%7.77M
-17.29%5.66M
-General & Admin Expense
-82.59%62.76M
+301.60%62.59M
+445.67%77.58M
+399.25%103.12M
+2509.44%360.42M
+35.34%15.59M
+34.46%14.22M
+280.09%20.65M
+118.68%13.81M
+65.94%11.52M
+39.54%10.57M
-2.49%5.43M
-8.90%6.32M
+4.22%6.94M
-2.46%7.58M
-1.57%5.57M
+15.86%6.93M
+59.12%6.66M
+158.28%7.77M
-17.29%5.66M
Research & Development
-24.17%157.73M
+158.69%132.62M
+186.66%147.29M
+247.51%131.10M
+575.44%208.02M
+66.05%51.27M
+107.07%51.38M
+146.19%37.72M
+225.87%30.80M
+212.38%30.87M
+360.71%24.81M
-10.12%15.32M
+4.92%9.45M
-51.92%9.88M
-76.69%5.39M
-14.51%17.05M
-62.35%9.01M
+11.85%20.56M
+15.74%23.11M
+78.59%19.94M
Other Taxes
----
----
----
----
----
----
----
----
----
----
----
+78.35%-265.00K
+104.81%39.00K
+68.04%-542.00K
+77.39%-793.00K
+67.92%-1.22M
+80.73%-810.00K
+53.90%-1.70M
---3.51M
---3.82M
Other Operating Expenses
----
----
----
----
----
----
----
----
----
----
----
----
+99.46%-12.00K
+98.65%-42.00K
+68.55%-340.00K
-325.93%-4.24M
-15.03%-2.20M
-75.76%-3.11M
+43.11%-1.08M
+43.14%-995.00K
Operating Profit
+61.21%-220.50M
-192.01%-195.21M
-242.80%-224.88M
-301.20%-234.21M
-1174.24%-568.44M
-57.71%-66.85M
-81.17%-65.60M
-184.88%-58.38M
-182.45%-44.61M
-161.03%-42.39M
-206.06%-36.21M
-20.97%-20.49M
-24.44%-15.79M
+26.71%-16.24M
+54.56%-11.83M
+13.07%-16.94M
+46.51%-12.69M
-30.93%-22.16M
-125.93%-26.04M
-21.17%-19.49M
Net Non-Operating Interest Income (Expense)
----
----
+100.00%0.00
+100.00%0.00
----
----
+99.69%-9.00K
+9.85%-2.45M
-23.34%-3.10M
+62.52%-3.12M
-108.27%-2.90M
-293.35%-2.72M
-285.15%-2.52M
-5378.29%-8.33M
-69650.00%-1.39M
---692.00K
-202.31%-653.00K
---152.00K
--2.00K
--0.00
Non-Operating Interest Income
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--1.51M
--0.00
--0.00
----
----
----
Non-Operating Interest Expense
----
----
-100.00%0.00
-100.00%0.00
----
----
-99.69%9.00K
-9.85%2.45M
+23.34%3.10M
-62.52%3.12M
-0.24%2.90M
+293.35%2.72M
+285.15%2.52M
+5378.29%8.33M
+145300.00%2.90M
--692.00K
+202.31%653.00K
--152.00K
---2.00K
--0.00
Other Income (Expense)
+75.74%4.80M
+46.98%5.79M
+30.16%5.75M
-47.18%2.42M
+121.53%2.73M
+93.32%3.94M
+74.02%4.42M
+135.25%4.58M
-452.81%-12.67M
+100.39%2.04M
+142.28%2.54M
+151.85%1.95M
+204.85%3.59M
-56815.22%-517.81M
-469.92%-6.01M
-3221.24%-3.75M
-628.94%-3.43M
+261.59%913.00K
+39.94%-1.05M
+93.42%-113.00K
Gain on Sale of Security
+54.42%4.30M
+46.98%5.79M
+30.16%5.75M
-47.18%2.42M
+19.19%2.78M
+93.32%3.94M
+67.17%4.42M
+127.76%4.58M
-35.11%2.33M
-24.22%2.04M
+21.73%2.64M
+152.91%2.01M
+205.42%3.60M
+189.03%2.69M
+273.21%2.17M
-12563.33%-3.80M
-777.12%-3.41M
--930.00K
---1.25M
---30.00K
Special Income (Charges)
----
----
--0.00
--0.00
----
----
--0.00
--0.00
---15.01M
----
+100.00%0.00
--0.00
--0.00
---520.92M
---8.47M
--0.00
--0.00
--0.00
----
----
-Less:Other Special Charges
----
----
----
----
----
----
--0.00
----
--15.01M
----
--0.00
----
----
--520.92M
----
----
----
----
----
----
Other Non-Operating Income (Expenses)
+1043.40%500.00K
----
--0.00
----
---53.00K
----
----
----
----
----
-135.99%-104.00K
-239.13%-64.00K
+64.29%-5.00K
+2552.94%417.00K
+44.50%289.00K
+155.42%46.00K
+82.72%-14.00K
+96.99%-17.00K
+111.06%200.00K
+90.33%-83.00K
Pretax Profit
+61.87%-215.70M
-201.09%-189.42M
-258.11%-219.12M
-312.05%-231.79M
-836.84%-565.71M
-44.72%-62.91M
-67.33%-61.19M
-164.50%-56.25M
-310.31%-60.39M
+91.98%-43.47M
-90.17%-36.57M
+0.55%-21.27M
+12.25%-14.72M
-2434.82%-542.38M
+29.04%-19.23M
-9.11%-21.39M
+31.31%-16.77M
-22.35%-21.40M
-99.82%-27.10M
-10.11%-19.60M
Net Profit
+61.87%-215.70M
-201.09%-189.42M
-258.11%-219.12M
-312.05%-231.79M
-836.84%-565.71M
-44.72%-62.91M
-67.33%-61.19M
-164.50%-56.25M
-310.31%-60.39M
+91.98%-43.47M
-90.17%-36.57M
+0.55%-21.27M
+12.25%-14.72M
-2434.82%-542.38M
+29.04%-19.23M
-9.11%-21.39M
+31.31%-16.77M
-22.35%-21.40M
-100.13%-27.10M
-10.46%-19.60M
Profit from Continuing Operations
+61.87%-215.70M
-201.09%-189.42M
-258.11%-219.12M
-312.05%-231.79M
-836.84%-565.71M
-44.72%-62.91M
-67.33%-61.19M
-164.50%-56.25M
-310.31%-60.39M
+91.98%-43.47M
-90.17%-36.57M
+0.55%-21.27M
+12.25%-14.72M
-2434.82%-542.38M
+29.04%-19.23M
-9.11%-21.39M
+31.31%-16.77M
-22.35%-21.40M
-100.13%-27.10M
-10.46%-19.60M
Net Income to Parent Company
+61.87%-215.70M
-201.09%-189.42M
-258.11%-219.17M
-312.05%-231.79M
-836.84%-565.71M
-44.72%-62.91M
-67.37%-61.20M
-164.50%-56.25M
-310.31%-60.39M
+91.98%-43.47M
-90.17%-36.57M
+0.55%-21.27M
+12.25%-14.72M
-2434.82%-542.38M
+29.04%-19.23M
-9.11%-21.39M
+31.31%-16.77M
-22.35%-21.40M
-100.13%-27.10M
-10.46%-19.60M
Net Income to Common Stockholders
+61.87%-215.70M
-201.09%-189.42M
-258.11%-219.17M
-312.05%-231.79M
-836.84%-565.71M
-44.72%-62.91M
-67.37%-61.20M
-164.50%-56.25M
-310.31%-60.39M
+91.98%-43.47M
-90.17%-36.57M
+0.55%-21.27M
+12.25%-14.72M
-2434.82%-542.38M
+29.04%-19.23M
-9.11%-21.39M
+31.31%-16.77M
-22.35%-21.40M
-100.13%-27.10M
-10.46%-19.60M
Basic EPS
+63.16%-0.28
-166.67%-0.24
-222.22%-0.29
-287.50%-0.31
-744.44%-0.76
-50.00%-0.09
-800.00%-0.09
-166.67%-0.08
-350.00%-0.09
+95.80%-0.06
+75.00%-0.01
+70.00%-0.03
+83.33%-0.02
-853.33%-1.43
+85.71%-0.04
+50.00%-0.10
+55.56%-0.12
+28.57%-0.15
-55.56%-0.28
+23.08%-0.20
Diluted EPS
+63.16%-0.28
-171.42%-0.24
-222.22%-0.29
-287.50%-0.31
-744.44%-0.76
-50.00%-0.09
-800.00%-0.09
-166.67%-0.08
-350.00%-0.09
+95.80%-0.06
+75.00%-0.01
+70.00%-0.03
+83.33%-0.02
-853.33%-1.43
+85.71%-0.04
+50.00%-0.10
+55.56%-0.12
+28.57%-0.15
-55.56%-0.28
+23.08%-0.20
Deadline
Jun 30, 2026
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Accounting Standard
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
2026/Q22026/Q12025/Q42025/Q32025/Q22025/Q12024/Q42024/Q32024/Q22024/Q12023/Q42023/Q32023/Q22023/Q12022/Q42022/Q32022/Q22022/Q12021/Q42021/Q3
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran situation is seeing new developments. According to Israel's Channel 12, a mediation proposal submitted by the Chief of Army St Show More